Biosimilar Drugs Webinar
Originally recorded on Tuesday, December 13, 2016
This webinar will provide an overview of the legislative and regulatory framework surrounding biosimilar drugs as well as present current issues for consideration including interchangeability, naming/labeling, implementation, and reimbursement.
Phil Johnson, MS RPh FHOPA FASHP
Moffitt Cancer Center, Director of Pharmacy (Retired)
Premier Inc., Oncology Director (Retired)
Edward Li, PharmD MPH BCOP
University of New England College of Pharmacy
Ali McBride, PharmD MS BCPS
The University of Arizona Cancer Center - The University of Arizona
This free event is open to HOPA members and non-members.
In case you missed it, view the webinar here.